SCHEMBL6597339

SCHEMBL6597339

CC(=O)Oc1c(C(C)C)c(-c2cc3ccccc3o2)oc(=O)c1C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CD74 P04233 1/20 0.45
MIF P14174 1/20 0.45
KDM4E B2RXH2 8/20 0.41
ALDH1A1 P00352 7/20 0.41
MAOB P27338 6/20 0.41
CYP1A2 P05177 3/20 0.41
MAOA P21397 3/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
CA12 O43570 2/20 0.40
CA9 Q16790 2/20 0.40
NT5E P21589 1/20 0.40
MEN1 O00255 4/20 0.39
KMT2A Q03164 4/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
NPC1 O15118 1/20 0.39
NFKB1 P19838 1/20 0.39
NPY1R P25929 1/20 0.39
RAB9A P51151 1/20 0.39
NFKB2 Q00653 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6594442 0.91 CD74 (0.45) CD74MIFKDM4EALDH1A1MAOB
SCHEMBL6591731 0.88 ALDH1A1 (0.41) CD74MIFKDM4EALDH1A1MAOB
SCHEMBL6595001 0.87 CD74 (0.49) CD74MIFKDM4EALDH1A1MAOB
SCHEMBL6597919 0.84 CD74 (0.47) CD74MIFKDM4EALDH1A1MAOB
SCHEMBL6592639 0.83 CD74 (0.46) CD74MIFKDM4EALDH1A1MAOB
SCHEMBL27557843 0.83 MAOB (0.46) CD74MIFKDM4EALDH1A1MAOB
SCHEMBL27541168 0.82 CD74 (0.45) CD74MIFKDM4EALDH1A1MAOB
SCHEMBL6592405 0.82 CD74 (0.45) CD74MIFKDM4EALDH1A1MAOB
SCHEMBL6594570 0.81 KDM4E (0.44) KDM4EALDH1A1MAOBCYP1A2MAOA
SCHEMBL6590458 0.80 MAOB (0.43) CD74MIFKDM4EALDH1A1MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1063235-B1 BENZOFURYLPYRONE DERIVATIVES TEIJIN LTD (JP) 2004-05-12 EP disclosed
US-20030186976-A1 Benzofurylpyrone derivatives TEIJIN LIMITED, MICROBIAL CHEMISTRY RESEARCH FOUNDATION 2003-10-02 US disclosed
US-6589984-B1 Blood cholesterol and triglycerides (TG) themselves are generally insoluble in blood, and they exist as lipoproteins by binding with apolipoproteins. In the body, triglycerides are biosynthesized primarily in the liver from acetyl CoA as TEIJIN LIMITED (JP) 2003-07-08 US disclosed
EP-1063235-A1 BENZOFURYLPYRONE DERIVATIVES TEIJIN LIMITED (JP) 2000-12-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030186976-A1 Benzofurylpyrone derivatives PLIN5, ACSL5, PLIN1 CD74 3720/4885MIF 4441/4885KDM4E 1274/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.